Paper36768432
Natural Killer Cell-Based Immunotherapy against Glioblastoma.
Morimoto T and 5 others. Int J Mol Sci, 2023. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Natural Killer Cell-Based Immunotherapy against Glioblastoma. Papers, record 36768432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Brain Neoplasms | Major topic |
| Adult | |
| Humans | |
| Immunotherapy | |
| Killer Cells, Natural | |
| Immunotherapy, Adoptive | |
| Tumor Microenvironment |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22K16667 | a Grand-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan | PubMed |
Source PubMed
References213
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27221712 | Dephosphorylation of the adaptor LAT and phospholipase C-γ by SHP-1 inhibits natural killer cell cytotoxicity. | Sci Signal | 2016 | https://conductscience.org/library/papers/27221712 | PubMed |
| 2 | 30666307 | Engineering and Design of Chimeric Antigen Receptors. | Mol Ther Methods Clin Dev | 2019 | https://conductscience.org/library/papers/30666307 | PubMed |
| 3 | 28486109 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28486109 | PubMed |
| 4 | 30224810 | CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. | Nat Neurosci | 2018 | https://conductscience.org/library/papers/30224810 | PubMed |
| 5 | 25584137 | Autologous therapies in dermatology. | J Clin Aesthet Dermatol | 2014 | https://conductscience.org/library/papers/25584137 | PubMed |
| 6 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 7 | 31409707 | Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31409707 | PubMed |
| 8 | 32826231 | Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia. | Cancer Discov | 2020 | https://conductscience.org/library/papers/32826231 | PubMed |
| 9 | 34836966 | Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. | Nat Commun | 2021 | https://conductscience.org/library/papers/34836966 | PubMed |
| 10 | 26806484 | Natural killer cell memory in infection, inflammation and cancer. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26806484 | PubMed |
| 11 | 22854781 | A restricted cell population propagates glioblastoma growth after chemotherapy. | Nature | 2012 | https://conductscience.org/library/papers/22854781 | PubMed |
| 12 | 30702189 | Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30702189 | PubMed |
| 13 | 29435173 | CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes. | Oncotarget | 2018 | https://conductscience.org/library/papers/29435173 | PubMed |
| 14 | 9730896 | Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. | J Exp Med | 1998 | https://conductscience.org/library/papers/9730896 | PubMed |
| 15 | 30840664 | Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro. | PLoS One | 2019 | https://conductscience.org/library/papers/30840664 | PubMed |
| 16 | 35864254 | Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. | Nat Med | 2022 | https://conductscience.org/library/papers/35864254 | PubMed |
| 17 | 29497427 | Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer. | Front Immunol | 2018 | https://conductscience.org/library/papers/29497427 | PubMed |
| 18 | 20147410 | NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. | J Virol | 2010 | https://conductscience.org/library/papers/20147410 | PubMed |
| 19 | 28426845 | HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28426845 | PubMed |
| 20 | 32457755 | Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma. | Front Immunol | 2020 | https://conductscience.org/library/papers/32457755 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940171 | Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940171 | PubMed |
| 42652153 | Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652153 | PubMed |
| 42540549 | Chromosomal instability is associated with paradoxical cGAS upregulation and impaired STING signaling shaping the immune microenvironment in glioblastoma. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42540549 | PubMed |
| 42465775 | The immunosuppressive tumor microenvironment in glioblastoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465775 | PubMed |
| 41998834 | Natural Product 4-Acetylantroquinonol B Enhances NK Cell-Mediated Immunity Against Glioblastoma. | Cancer Med | 2026 | https://conductscience.org/library/papers/41998834 | PubMed |
| 41929521 | Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929521 | PubMed |
| 41929516 | Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41929516 | PubMed |
| 41913181 | Glioblastoma-natural killer cell crosstalk: insights from dynamic spheroid models reveal the importance of secreted cytokines and the CD155 axis. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41913181 | PubMed |
| 41601660 | Natural killer cell-based senotherapy: a promising strategy for healthy aging. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601660 | PubMed |
| 41463154 | Cell-Surface PCNA Is Co-Expressed with Biomarkers of Stemness and Immunosuppression in Glioblastoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463154 | PubMed |
| 41403931 | Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41403931 | PubMed |
| 41179878 | The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41179878 | PubMed |
| 41030289 | Cell therapies against brain tumors: Clinical development and emerging prospects. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/41030289 | PubMed |
| 40974256 | Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/40974256 | PubMed |
| 40924328 | Photodynamic therapy for glioblastoma: a narrative review. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40924328 | PubMed |
| 40696929 | Immunotherapy in central nervous system tumors. | Int J Surg | 2025 | https://conductscience.org/library/papers/40696929 | PubMed |
| 40628732 | Glioblastoma at the crossroads: current understanding and future therapeutic horizons. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40628732 | PubMed |
| 40426086 | The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40426086 | PubMed |
| 40352591 | Expanding horizons of cancer immunotherapy: hopes and hurdles. | Front Oncol | 2025 | https://conductscience.org/library/papers/40352591 | PubMed |
| 39669560 | A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence. | Front Immunol | 2024 | https://conductscience.org/library/papers/39669560 | PubMed |
Genes94
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768432
GET https://conductscience.org/api/papers/v1/36768432/references?page=2